Amyotrophic lateral sclerosis mimic syndromes: a population-based study.

  title={Amyotrophic lateral sclerosis mimic syndromes: a population-based study.},
  author={Bryan J. Traynor and Mary B. Codd and Bernie Corr and Claire Forde and Eithne Frost and Orla Hardiman},
  journal={Archives of neurology},
  volume={57 1},
BACKGROUND The Irish ALS Register is a population-based register of the epidemiological characteristics of amyotrophic lateral sclerosis (ALS) in the republic of Ireland. OBJECTIVE To describe the clinical and demographic details of those patients included in the Irish ALS Register who were incorrectly diagnosed as having ALS (patients who were ultimately rediagnosed as having an "ALS mimic syndrome"). METHODS The medical records of each patient referred to the register are routinely… 

Tables from this paper

Epidemiology and Clinical Description of Amyotrophic Lateral Sclerosis in Low Income Setting: A Syndrome with Short Survival
This observation highlighted the major difficulties encountered in the management of ALS and its increasing frequency in south Saharan Africa.
Amyotrophic lateral sclerosis: Analysis of ALS cases in a predominantly admixed population of Ecuador
Investigation in the predominantly admixed population of Ecuador found that ALS incidence in the Ecuadorian hospital population is in accord with rates reported in recent studies for other admixed populations, and lower than that in the United States and Europe.
Early diagnosis of amyotrophic lateral sclerosis mimic syndromes: pros and cons of current clinical diagnostic criteria
Early identification of ALS mimic syndromes is possible based on atypical clinical features and a clinically-guided electrophysiological study and the application of El Escorial revised criteria (EECr) helps to identify ALS misdiagnoses.
Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues
The contribution of the various population based registers is outlined, the limitations of the existing datasets are identified and a mechanism to improve the future design and output of descriptive epidemiological studies is proposed.
Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study.
The El Escorial and Airlie House diagnostic criteria for amyotrophic lateral sclerosis are excessively restrictive and levels of diagnostic certainty cannot be used as prognostic indicators.
Predictors of amyotrophic lateral sclerosis mimic syndrome
From the series of patients, atypical symptoms, absence of EMG pathological findings or isolated upper or lower motor neuron disease should prompt suspicion of a differential diagnosis of ALS misdiagnosis.
Diagnostic dilemma of amyotrophic lateral sclerosis (ALS): insights from the first ALS specialized clinic in Egypt
The percentage of ALS mimics in this study is higher than that reported in previous studies and could be due to the small sample size and the deficiency of specialized ALS centers across the country.
Amyotrophic Lateral Sclerosis Descriptive Epidemiology: The Origin of Geographic Difference
The demographic changes related to increased expectation of life and the growth of the world population indicate that the load of motor neuron disease is rapidly moving toward 400 thousand prevalent cases and the burden is expected to shift toward Asia and Africa in the next decades for the rapid increase of expectation oflife of countries with high demographic impact.
Epidemiology of ALS in Italy
In the examined decade, the incidence of amyotrophic lateral sclerosis in Italy has been stable, and the clinical and demographic characteristics of the patients have shown no relevant modifications.
A retrospective study of the clinical phenotype and predictors of survival in non-Caucasian Hispanic patients with amyotrophic lateral sclerosis
It was found that bulbar-onset, short diagnostic delay, percutaneous endoscopic gastrostomy, mechanical ventilation, and lower total cholesterol serum levels were associated with short survival.


Misdiagnosis in patients with amyotrophic lateral sclerosis.
Most likely causes of misdiagnosis were physicians' failure to consider the diagnosis and lack of familiarity with the common clinical presentations of amyotrophic lateral sclerosis.
Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction.
Over 1200 patients with motor neuron disease have been carefully diagnosed, followed, and included in a detailed database delineating characteristics of the disease. Of these patients, 831 were
Spinobulbar muscular atrophy can mimic ALS: The importance of genetic testing in male patients with atypical ALS
This study underscores the difficulty in distinguishing SBMA from ALS clinically, particularly in patients who lack the classic signs of each disease, and shows that ALS was clinically misdiagnosed in 2% of sporadic cases and in two of the 100 FALS kindreds.
Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register.
Patients with MND should undergo thorough and relevant investigations at presentation with the emphasis on neuroradiological imaging and neurophysiology; all patients should be followed up by an experienced neurologist; failure of symptom progression or development of atypical features should lead to an early reassessment; and patients are informed of the diagnosis only when it is secure.
Motor neuropathies mimicking amyotrophic lateral sclerosis/motor neuron disease
Diagnosing motor neurone disease
Advanced motor neurone disease is easily recognised. Progressively worsening dysphagia and dysarthria, and widespread wasting and weakness of the limbs with hyperactive reflexes in a corresponding
Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies
ELISA is a useful diagnostic test to demonstrate IgM anti-GM1 antibodies provided the methods do not use detergent and do incubate serum overnight.
Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
It is concluded that enlargement of the CAG repeat in the androgen receptor gene is probably the cause of X-LINKED spinal and bulbar muscular atrophy.
Motor neurone disease: a demeaning illness.
  • R. Carus
  • Education
    British medical journal
  • 1980
I wish with all my heart and soul that I had not written this paper; for then I should still be where I spent five years' training to be, and where I planned to spend these years of my life, at work
Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study.
IVIg treatment can lead to improvement of muscle strength in patients with MMN, and this effect was confirmed for each patient in a single patient, double blind, placebo controlled trial.